It reads like they know they need more capital but do not want to do a raising when prices are so low. Sounds like they're going to try to get debt funding for part, wait till the stock is re-rated then possibly do a raising.
As an existing shareholder I'm not against that approach.
Tough to get lined up though and with the cash position getting so close to the edge it seems like a pretty bullish call from mgt. They're backing themselves, which I like to see.
- Forums
- ASX - By Stock
- Ann: Offer Document for Entitlement Offer
It reads like they know they need more capital but do not want...
Featured News
Add STX (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.8¢ |
Change
-0.003(1.09%) |
Mkt cap ! $659.0M |
Open | High | Low | Value | Volume |
22.5¢ | 23.0¢ | 22.5¢ | $356.2K | 1.583M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 198256 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 2103572 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 247357 | 0.225 |
17 | 1955820 | 0.220 |
16 | 1142601 | 0.215 |
27 | 1023931 | 0.210 |
24 | 1135731 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 2090252 | 13 |
0.235 | 3927575 | 30 |
0.240 | 2819158 | 21 |
0.245 | 2406228 | 21 |
0.250 | 2841658 | 28 |
Last trade - 10.38am 12/11/2024 (20 minute delay) ? |
Featured News
STX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online